Skip to content

Revise by topic

Skin & soft tissue for FRCS (Plast)

Skin and soft tissue covers the cutaneous malignancies and the lumps a plastic surgeon is asked to diagnose and treat. Basal cell carcinoma, cutaneous squamous cell carcinoma and melanoma form the core: risk stratification, excision margins, Mohs surgery, and when to involve the specialist skin cancer multidisciplinary team. Melanoma questions span diagnosis, Breslow thickness and staging, and sentinel lymph node biopsy. Vascular anomalies are classified by ISSVA into tumours, chiefly infantile haemangioma, and malformations, and that distinction drives management. The category also covers soft tissue tumours and sarcoma, where the safe answer is often to image and refer before any biopsy, and benign and premalignant lesions such as actinic keratosis, Bowen’s disease and naevi. Thresholds here are precise and guideline-based, so they make natural discriminators.

166 questions in the bank · 6 topics Updated 3 October 2026

Topics in this domain

  • Basal cell carcinoma25
  • Squamous cell carcinoma26
  • Melanoma45
  • Vascular anomalies20
  • Soft tissue tumours & sarcoma25
  • Benign & premalignant lesions25

What the paper tends to test

  • Expect margin questions framed around a patient: the margin depends on tumour type, stage or risk group and site, and the options will be close together.
  • The paper tends to test sentinel lymph node biopsy indications — when to offer or consider it in melanoma, and why it is not routine in cSCC.
  • Expect risk stratification in BCC and cSCC: site, size, histological subtype, perineural invasion and immunosuppression all change the answer.
  • Vascular anomaly questions usually hinge on separating tumours from malformations and choosing first-line treatment, such as propranolol for problematic infantile haemangioma.
  • Soft tissue mass questions test the features that warrant imaging and sarcoma-service referral, and the order of investigation.

Classic traps and discriminators

  • Melanoma margins under NICE NG14 (2022): consider at least 0.5 cm for stage 0, use 1 cm for stage I and 2 cm for stage II, with 1 cm acceptable where 2 cm would cause unacceptable disfigurement or morbidity.
  • NICE NG14 does not offer sentinel lymph node biopsy for stage IA melanoma; consider it for Breslow thickness above 1.0 mm, or 0.8–1.0 mm with ulceration, lymphovascular invasion or a mitotic index of 2 or more.
  • BAD 2020 cSCC clinical margins are at least 4 mm for low-risk, 6 mm for high-risk and 10 mm for very-high-risk tumours. Sentinel node biopsy is not routine in cSCC, unlike melanoma and Merkel cell carcinoma.
  • Infantile haemangiomas are GLUT1-positive and proliferate after birth; congenital haemangiomas (RICH and NICH) are fully formed at birth and GLUT1-negative.
  • A soft tissue mass that is deep to fascia, enlarging or larger than 5 cm needs imaging and sarcoma-service referral before biopsy; an unplanned excision compromises definitive surgery.

Free skin & soft tissue practice questions

From the free sample — original, referenced, with the full explanation. Rate your confidence first.

03Skin & soft tissue·Basal cell carcinoma
medium

A 71-year-old man has a slowly enlarging, flat, ivory-coloured indurated plaque on the forehead with indistinct edges, which he attributes to an old scar although he recalls no injury. Histology shows thin strands of basaloid cells one to two cells thick embedded in a dense sclerotic stroma.

Which subtype of basal cell carcinoma is this?

How sure are you?
04Skin & soft tissue·Squamous cell carcinoma
medium

Nine months after excision of a 20 mm squamous cell carcinoma of the cheek with clear margins, a 72-year-old man develops numbness of the cheek and upper lip with intermittent shooting pain below the orbit. The scar is soft and no nodes are palpable.

Which investigation is most appropriate?

How sure are you?

Skin & soft tissue questions, answered

What melanoma excision margins should I know for FRCS (Plast)?

Those in NICE NG14 (2022): consider at least 0.5 cm for stage 0, 1 cm for stage I and 2 cm for stage II, with 1 cm acceptable where 2 cm would cause unacceptable disfigurement or morbidity. Questions usually test applying them to a specific patient and site.

Is sentinel lymph node biopsy used in cutaneous SCC?

Not routinely. Outside a clinical trial or a specialist MDT decision it is not standard care in cSCC, which makes it a common distractor, because sentinel node biopsy is standard staging in melanoma and Merkel cell carcinoma.

Are vascular anomalies in the skin or the paediatric section?

Both. They sit in skin and soft tissue in the curriculum and recur in paediatric practice. The ISSVA division into vascular tumours and vascular malformations is the starting point either way.

Drill skin & soft tissue tonight

Create a free account, filter the bank to this domain and rate your confidence as you go. Upgrade when you want the full bank and two-paper mocks.